Literature DB >> 99418

Bioavailability and pharmacokinetics of cefoxitin sodium.

J J Schrogie, R O Davies, K C Yeh, D Rogers, G I Holmes, H Skeggs, C M Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 99418     DOI： 10.1093/jac/4.suppl_b.69

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  21 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.

Authors:  Raphaël Lepeule; Etienne Ruppé; Patrick Le; Laurent Massias; Françoise Chau; Amandine Nucci; Agnès Lefort; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

3.  Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.

Authors:  Arantxazu Isla; Iñaki F Trocóniz; Ignacio López de Tejada; Silvia Vázquez; Andrés Canut; Jesús Muriel López; María Ángeles Solinís; Alicia Rodríguez Gascón
Journal:  Eur J Clin Pharmacol       Date:  2012-01-15       Impact factor: 2.953

4.  Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.

Authors:  A S Beale; J Gisby
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

5.  Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.

Authors:  M J Otero; M J Garcia; M Barrueco; A Dominguez-Gil; F Gomez; J Portugal Alvarez
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.

Authors:  M Ohkawa; M Orito; T Sugata; M Shimamura; M Sawaki; E Nakashita; K Kuroda; K Sasahara
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

7.  Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.

Authors:  E J Van Hoogdalem; A T Wackwitz; A G De Boer; A F Cohen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

8.  Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers.

Authors:  H Ko; E Novak; G R Peters; W M Bothwell; J D Hosley; S K Closson; W J Adams
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

9.  Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.

Authors:  H Ko; K S Cathcart; D L Griffith; G R Peters; W J Adams
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

10.  Use of adjuvants for enhancement of rectal absorption of cefoxitin in humans.

Authors:  S S Davis; W R Burnham; P Wilson; J O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.